**Contents**


Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints Reprinted from: *Int. J. Mol. Sci.* **2022**, *23*, 1711, doi:10.3390/ijms23031711 . . . . . . . . . . . . . . **137**


MDA-MB-231 Human Breast Cancer Cells

Reprinted from: *Int. J. Mol. Sci.* **2020**, *21*, 5080, doi:10.3390/ijms21145080 . . . . . . . . . . . . . . **325**


Reprinted from: *Int. J. Mol. Sci.* **2020**, *21*, 7779, doi:10.3390/ijms21207779 . . . . . . . . . . . . . . **389**

of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2
